A few weeks ago, St. Jude Medical Inc. marked the one-year anniversary of its acquisition of Atlanta, GA, company CardioMEMS Inc., developer of the CardioMEMS HF System, which became the first FDA-approved heart failure monitor that is proven to significantly reduce HF hospital admissions and improve quality of life in New York Heart Association (NYHA) class III patients.
To recap, the St Paul, MN, company took a 19% stake in CardioMEMS in 2010, and also took an option...